PURESPRING THERAPEUTICS LIMITED
Research and experimental development on biotechnology
PURESPRING THERAPEUTICS LIMITED
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Registered Address
8 Bloomsbury Street London WC1B 3SR England
Full company profile for PURESPRING THERAPEUTICS LIMITED (12543677), an active life sciences and medical technology company based in London, England. Incorporated 1 Apr 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2020–2024)
Cash in Bank
£28.02M
Net Assets
£29.78M
Total Liabilities
£4.22M
Turnover
N/A
Employees
46
Debt Ratio
12%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2022 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (5)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 5 | Nov 2020 | Series B, Series A |
| Investor 1 | Oct 2024 | Series B |
| Investor 2 | Oct 2024 | Series B |
See all 5 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Arthur Lodewijk Franken | Director | Dutch | Netherlands | 6 Dec 2024 | Active |
| Michael Kyriakides | Director | British | England | 13 Apr 2022 | Active |
See all 14 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (2)
Syncona Limited
British Channel Islands
- Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors
Syncona Limited
Unknown
- Ownership Of Shares 25 To 50 Percent
- Voting Rights 25 To 50 Percent
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 17 Apr 2026 | Confirmation Statement | Confirmation statement made on 2026-03-31 with updates | |
| 16 Apr 2026 | Persons With Significant Control | Change to Syncona Limited as a person with significant control on 2024-10-08 | |
| 16 Apr 2026 | Persons With Significant Control | Change to Syncona Limited as a person with significant control on 2025-10-31 | |
| 17 Dec 2025 | Capital | Allotment of shares (GBP 1,517.58543) on 2025-12-12 | |
| 15 Dec 2025 | Capital | Allotment of shares (GBP 1,411.99641) on 2025-09-04 |
Confirmation statement made on 2026-03-31 with updates
Change to Syncona Limited as a person with significant control on 2024-10-08
Change to Syncona Limited as a person with significant control on 2025-10-31
Allotment of shares (GBP 1,517.58543) on 2025-12-12
Allotment of shares (GBP 1,411.99641) on 2025-09-04
Recent Activity
Latest Activity
Confirmation statement made on 2026-03-31 with updates
2 days ago on 17 Apr 2026
Change to Syncona Limited as a person with significant control on 2024-10-08
3 days ago on 16 Apr 2026
Change to Syncona Limited as a person with significant control on 2025-10-31
3 days ago on 16 Apr 2026
Allotment of shares (GBP 1,517.58543) on 2025-12-12
4 months ago on 17 Dec 2025
Allotment of shares (GBP 1,411.99641) on 2025-09-04
4 months ago on 15 Dec 2025